Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1552 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Focal Dermal Hypoplasia | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| FDH; Goltz syndrome | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Focal dermal hypoplasia (FDH; MIM 305600), also known as Goltz syndrome or Goltz-Gorlin syndrome is an X-linked dominant disorder caused by mutations in the PORCN gene. PORCN encodes a putative O-acyltransferase involved in palmitoylation of Wnt signaling proteins which play important roles in embryonic development. Individuals with PORCN mutations have defects in ectodermal and mesodermal tissues. The skin, eyes, skeleton and teeth are primarily affected in patients with FDH. Typical skin findings include linear or reticular hyperpigmentation or hypopigmentation, patchy skin atrophy, hairlessness, deposition of subcutaneous fat into the dermis, papillomas of the mucosa and nail dysplasia. Eye findings include coloboma, microphthalmia, aniridia, unilateral anophthalmia, corneal opacities and cataracts. Skeletal findings include asymmetrical skeletal defects, syndactyly, brachydactyly, oligodactyly, ectrodactyly and polydactyly. Additional findings include microcephaly, cleft lip/palate, facial asymmetry, short stature, diastasis pubis and osteopathia striata. Abnormalities of the teeth include, hypodontia, oligodontia, hypoplasia of the enamel, delayed eruption and malocclusion. Kidney or urinary tract malformations including horseshoe kidney, bilateral kidney hypoplasia, hydronephrosis and bifid ureter have also been documented. Mental retardation occurs in about 15% of patients with FDH. Females represent about 90% of individuals with FDH. About 95% of the female cases and almost all male cases appear to be de novo. Most females with FDH display extreme skewing of X-chromosome inactivation. Some females and the majority of males have postzygotic de novo mutations resulting in functional mosaicism. Some male cases may be explained by a 47, XXY karyotype. The phenotype seems to be dependent, to some extent, on the degree of functional mosaicism. Because of the mosaicism, DNA sequence analysis of any one cell type may not be highly sensitive for mutation detection. The prevalence of FDH is not known. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| PORCN | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 305600 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Ophthalmology, Skeletal Disorders, Skin | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.